Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs

Bibliographic Details
Main Authors:	Bendall, L, Fenwick, J, Papiez, B, Hawkins, M
Format:	Conference item
Published:	Elsevier 2018

Similar Items

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
by: Warren, S, et al.
Published: (2014)

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
by: Panettieri, V, et al.
Published: (2010)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
by: Dong Joo Rhee, PhD, et al.
Published: (2023-07-01)

Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
by: Raphael Bodensohn, et al.
Published: (2024-03-01)

Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
by: Sebastian H. Maier, et al.
Published: (2024-07-01)

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy
by: Denis Panizza, et al.
Published: (2022-04-01)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
by: Warren, S, et al.
Published: (2014)

Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system
by: Sreenija Yarlagadda, et al.
Published: (2024-07-01)

Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion
by: Berardino De Bari, et al.
Published: (2024-02-01)

Analysis of tumour control probability, normal tissue complication probability and isotoxic effects for prostate cancer
by: Fauzee, Nurnada Syahrain Mohd
Published: (2016)

Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy
by: Zhigong Wei, et al.
Published: (2021-08-01)

Radiation treatment planning with embedded dose escalation
by: William T. Hrinivich, et al.
Published: (2019-08-01)

Radiation dose escalation in stage III non-small-cell lung cancer.
by: William Thomas Sause, et al.
Published: (2011-11-01)

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer
by: Lester, J, et al.
Published: (2012)

Personalized dose escalation in anal cancer
by: Robinson, M, et al.
Published: (2016)

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION
by: Auchynikau V. A., et al.
Published: (2018-09-01)

Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linac
by: Amanda Moreira, et al.
Published: (2024-03-01)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
by: Stefania Naccarato, PhD, et al.
Published: (2022-05-01)

Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer
by: Simon Boeke, et al.
Published: (2022-11-01)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2018-11-01)

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data
by: Emily S. Weg, MD, et al.
Published: (2019-07-01)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
by: Nana Shimoyachi, MD, et al.
Published: (2021-11-01)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
by: Christelle Bouchart, et al.
Published: (2021-10-01)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
by: Lin-Rui Gao, et al.
Published: (2023-01-01)

A planning study of proton therapy dose escalation for non-small cell lung cancer
by: Arno C. Hessels, et al.
Published: (2024-07-01)

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody
by: Yan Wang, et al.
Published: (2020-01-01)

Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy
by: Annika eJakobi, et al.
Published: (2015-11-01)

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
by: Skinner Heath D, et al.
Published: (2013-01-01)

Dose escalation of a curcuminoid formulation
by: Crowell James, et al.
Published: (2006-03-01)

Treatment planning of dose escalation for anal cancer in the PLATO trial
by: Abbott, N, et al.
Published: (2017)

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
by: Jennifer Dang, et al.
Published: (2022-09-01)

Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
by: Michael H. Wang MD, et al.
Published: (2022-09-01)

Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
by: Alex Dunlop, et al.
Published: (2020-07-01)

Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)
by: Jeremiah de Leon, et al.
Published: (2021-11-01)

Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR
by: Jong Min Park, et al.
Published: (2019-06-01)

Introduction of radiation therapist‐led adaptive treatments on a 1.5 T MR‐Linac
by: Maddison Picton, et al.
Published: (2023-04-01)

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
by: Katrien De Wolf, et al.
Published: (2017-09-01)

Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer
by: Andreas Köthe, et al.
Published: (2021-10-01)